PDS Health®, a leading integrated healthcare support organization, provided $92,079 in donated oral health care to 27 ...
The majority of the PDS Health-affiliated practices share a perception among former patients that the staff exaggerated their ...
Analysts expect PDS Biotechnology to report an earnings per share (EPS) of $-0.20. PDS Biotechnology bulls will hope to hear ...
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Pds Biotechnology (($PDSB)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of PDS ...
PDS Biotechnology Corporation (NASDAQ: PDSB) Q3 2025 Earnings Call Transcript November 13, 2025 ...
Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms natural killer (NK) cells to possess characteristics ...
President John Dramani Mahama has said that the Power Distribution Services (PDS) concession arrangement did not fail because it was fundamentally defective, but rather due to mismanagement and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback